Adar1 Capital Management, LLC Lexaria Bioscience Corp. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 945 shares of LEXX stock, worth $3,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
945
Previous 26,626
96.45%
Holding current value
$3,118
Previous $96.7 Million
97.28%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding LEXX
# of Institutions
29Shares Held
2.06MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.02MShares$3.37 Million0.04% of portfolio
-
Invenomic Capital Management LP Boston, MA514KShares$1.69 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA115KShares$378,7830.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA93.6KShares$308,8330.0% of portfolio
-
Gen Trust, LLC60KShares$198,0000.01% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $19.6M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...